SCHEMBL14837184

SCHEMBL14837184

Cn1c(CNCc2ccc(-c3c[nH]c(=O)c4c3CCCC4)o2)nc2ccccc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 5/20 0.39
▸ KMT2A Q03164 4/20 0.39
▸ NPC1 O15118 12/20 0.39
▸ RAB9A P51151 12/20 0.39
▸ SMN1; SMN2 Q16637 5/20 0.39
▸ KDM4E B2RXH2 3/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ MAPT P10636 3/20 0.37
▸ L3MBTL1 Q9Y468 2/20 0.37
▸ GAA P10253 2/20 0.37
▸ DDB1 Q16531 1/20 0.37
▸ CRBN Q96SW2 1/20 0.37
▸ TP53 P04637 2/20 0.36
▸ ALOX15 P16050 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14837159 0.80 KMT2A (0.41) KMT2ARAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL918232 0.77 PARP1 (0.35) KMT2ASMN1; SMN2ALDH1A1HSD17B10L3MBTL1
SCHEMBL14836947 0.75 PARP1 (0.39) KMT2ASMN1; SMN2NPSR1
SCHEMBL14837487 0.74 ACHE (0.40) KMT2AKDM4EALDH1A1HPGDMEN1
SCHEMBL917909 0.74 PARP1 (0.39) USP2
SCHEMBL917709 0.72 KDM4E (0.48) LMNAKMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL5608972 0.69 NPC1 (0.73) LMNAKMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL917974 0.69 CYP2A6 (0.39) CYP1A2CYP3A4CYP2C9
SCHEMBL14837200 0.68 PARP1 (0.43) LMNAKMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL14837106 0.68 KMT2A (0.43) LMNAKMT2ASMN1; SMN2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1758864-B1 Substituted tetrahydro-2H-isoquinolin-1-one derivatives, method for their preparation, and their use as medicaments SANOFI AVENTIS DEUTSCHLAND (DE) 2013-04-10 — — EP disclosed
CN-1968929-B Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof, and use of the same as medicaments SANOFI AVENTIS DEUTSCHLAND 2010-09-08 — — CN disclosed
Send feedback